MedPath

Investigation of the efficacy of Esomeprazole for 8 weeks to the proton pomp inhibitor (PPI)-resistant gastro-esophageal reflux disease (GERD) patients

Not Applicable
Conditions
Gastroesophageal
Registration Number
JPRN-UMIN000012000
Lead Sponsor
ationalOrganizationHospital Fukuyama medical center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Severe liver function failure (AST or ALT >100IU/l) 2. Severe heart failure 3. Patients with malignant disease 4. Patients with HIV positive or AIDS 5. Patients received vagolysis 6. Patients received surgery with upper gastrointestinal tract 7. Patients prescribed prohibited concomitant drugs 8. Patients having allergy for Esomeprazole or the similar drugs 9. Patients having difficulty of writing questionnaire sheets 10. Patients who are pregnant 11. Nursing wemen

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath